Quest Diagnostics Inc (DGX) Stock Price Today
Aura AI Summary
Key Stats
- $23.51BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $216.02FIFTY_TWO_WEEK_HIGH
- $166.42FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $29.52BENTERPRISE_VALUE
- 1.62%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Quest Diagnostics Inc (DGX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $166.42 and a high of $216.02, highlighting its annual price range. Buy and sell Quest Diagnostics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Most Recent News
Global golf simulators market to reach $5.5B by 2035 with 8.6% CAGR, driven by tech advances and rising home use
The global golf simulators market, valued at $2.4 billion in 2025, is projected to grow to $5.5 billion by 2035 at an 8.6% CAGR. Growth is fueled by technological improvements, increased commercial and residential use, and rising demand for indoor go...

Capital Power signs 10+ year deal to supply 250 MW to Meta's Alberta data centre by 2028
Capital Power Corporation has entered a long-term energy supply agreement to provide 250 megawatts of power to Meta's new data centre in Sturgeon County, Alberta, expected to be operational in late 2028. This deal strengthens Capital Power's position...

Class action lawsuit filed over Megan Holdings' alleged misleading IPO disclosures causing investor losses.
A securities class action lawsuit has been filed against Megan Holdings Limited by investors who purchased shares during its September 2025 IPO or between September 2025 and May 2026. The lawsuit alleges the company made false and misleading statemen...
